News and Announcements
Bhumi’s Co-founder Vinita Talks About the Myth Behind Thread Count
- Published June 18, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Key Takeaways:
- Don’t fall into the thread count gimmick
- higher thread count doesn’t necessarily translate into higher quality
- the quality of the product depends directly on the weaving process and the quality of the fibre and yarn used
Thread count matters but not as much as it is marketed it to be. It is the number of horizontal and vertical threads in 1 square inch of woven cotton. Contrary to popular belief, higher thread count doesn’t necessarily translate into higher quality – the quality of the product depends directly on the weaving process and the quality of the fibre and yarn used.
Apart from the marketing ‘gimmicks’ (creative counting or double counting of threads), this concept may sometimes be confusing for consumers – the analogy we like to use to illustrate this point is of healthy vs. unhealthy hair. 50 strands of unhealthy hair or 100 strands of unhealthy hair is still considered unhealthy hair. More strands of unhealthy hair do not improve the underlying hair quality. The same is true for cotton and thread count.
Simply put:
- We don’t recommend paying more dollars just for higher thread count, and
- Make sure you are not falling into the marketing ‘gimmicks’ of thread count.
About Bhumi
Bhumi was founded to offer consumers industry leading bedding and everyday essentials that are made with the greater good in mind. We directly source the world’s finest organic cotton to create luxuriously soft products, all while remaining rooted in fairness from farmer to factory worker. Bhumi offers luxuriously soft organic cotton bedding, sheets, towels and everyday clothing basics and activewear.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
